Related Experiment Video
Updated: Aug 7, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
Autistic regression associated with seizure onset in an infant with tuberous sclerosis
Ayla Humphrey1, Brian G R Neville, Antonia Clarke
1Developmental Psychiatry Section, University of Cambridge, UK. ah290@cam.ac.uk
Insights
This case study highlights how early-onset epilepsy in tuberous sclerosis can lead to autistic regression and developmental disorders. It questions whether vigabatrin
Area of Science:
- Neurodevelopmental disorders
- Pediatric epilepsy
- Autism spectrum disorder
Background:
- Tuberous sclerosis is a genetic disorder that can cause tumors to grow in various organs, including the brain.
- Early diagnosis and intervention are crucial for managing tuberous sclerosis and its associated complications.
- Epilepsy is a common comorbidity in tuberous sclerosis, often presenting in infancy.
Observation:
- A male infant diagnosed with tuberous sclerosis at 6 months received vigabatrin prophylactically.
- Vigabatrin was discontinued at 13 months due to concerns about visual field defects.
- The child developed infantile spasms and partial seizures with secondary generalization at 21 months.
Findings:
- Cognitive and social development were normal until seizure onset at 21 months.
- Autism and learning disability were diagnosed at 24 months.
- This suggests a link between early-onset epilepsy and autistic regression in tuberous sclerosis.
Implications:
- The timing of epilepsy onset in early brain development may influence neurodevelopmental outcomes.
- This case underscores the need to weigh the risks of vigabatrin (visual field defects) against the potential harm of uncontrolled seizures.
- Further research is needed to optimize treatment strategies for epilepsy in tuberous sclerosis to prevent developmental delays.
Abstract:
We report here on a male diagnosed with tuberous sclerosis at 6 months of age. The child was treated with vigabatrin at age 6 months after an abnormal electroencephalogram but before onset of seizures. Vigabatrin was discontinued at age 13 months to avoid possible visual field defects. At 21 months, the child developed partial seizures with secondary generalization and infantile spasms. Standardized developmental assessments were performed at 12, 18, 24, 30, and 36 months of age. Cognitive and social development were normal until age 21 months and the onset of seizures. When assessed at 24 months, the child met criteria for autism and learning disability. This case indicates that the onset of epilepsy during an early stage in brain development can be associated with autistic regression and persistent developmental disorder. The case suggests the need to consider if possible visual field defects with vigabatrin outweigh the potentially deleterious effects of uncontrolled seizures.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types
Seizures l: Introduction
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures ll: Types
